Literature DB >> 1716203

Conformational and epitope mapping of herpes-simplex-virus type-1 thymidine kinase using synthetic peptide segments.

N Zimmermann1, A G Beck-Sickinger, G Folkers, S Krickl, I Müller, G Jung.   

Abstract

Adjacent peptide segments covering the complete sequence of herpes-simplex-virus type-1 thymidine kinase (HSV1-TK) of 376 amino acids were synthesized in order to experimentally verify the three-dimensional structure of the HSV1-TK active site, which was previously determined by molecular modeling. 26 peptides have been prepared by multiple solid-phase synthesis using the 9-fluorenylmethoxycarbonyl strategy. The purified peptides were linked covalently to bovine serum albumin. The peptide/ELISA of the synthesized bovine-serum-albumin conjugates using polyclonal rabbit anti(HSV1-TK)serum resulted in ten epitopes, which correlate excellently with the computer-proposed active site of HSV1-TK. CD spectra of the HSV1-TK peptides were recorded in trifluoroethanol/water (9:1 by vol.) An eigenvalue method based on CD spectra of 15 well known protein structures was used to calculate the relative percentage of secondary structures from the CD data. The computer model of the HSV1-TK showed full conformity with the folding pattern determined by CD of the synthetic peptide segments. Therefore, conformational peptide mapping with CD-based secondary structures combined with epitope mapping from the peptide/ELISA is an efficient and reliable method to support computer-aided protein design.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716203     DOI: 10.1111/j.1432-1033.1991.tb16213.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  A transferred NOE study of a tricyclic analog of acyclovir bound to thymidine kinase.

Authors:  J Czaplicki; T Bohner; A K Habermann; G Folkers; A Milon
Journal:  J Biomol NMR       Date:  1996-10       Impact factor: 2.835

Review 2.  Structural biology and diabetes mellitus: molecular pathogenesis and rational drug design.

Authors:  T Blundell; R Hubbard; M A Weiss
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.